BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34914058)

  • 1. Construction of Novel Live Genetically Modified BCG Vaccine Candidates Using Recombineering Tools.
    Flores-Valdez MA; Aceves-Sánchez MJ
    Methods Mol Biol; 2022; 2410():367-385. PubMed ID: 34914058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guérin, and Mycobacterium tuberculosis H37Rv by allelic exchange.
    Pavelka MS; Jacobs WR
    J Bacteriol; 1999 Aug; 181(16):4780-9. PubMed ID: 10438745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterial recombineering.
    van Kessel JC; Hatfull GF
    Methods Mol Biol; 2008; 435():203-15. PubMed ID: 18370078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterial recombineering.
    Murphy KC; Papavinasasundaram K; Sassetti CM
    Methods Mol Biol; 2015; 1285():177-99. PubMed ID: 25779316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis.
    Bardarov S; Bardarov S; Pavelka MS; Sambandamurthy V; Larsen M; Tufariello J; Chan J; Hatfull G; Jacobs WR
    Microbiology (Reading); 2002 Oct; 148(Pt 10):3007-3017. PubMed ID: 12368434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombineering in Mycobacterium tuberculosis.
    van Kessel JC; Hatfull GF
    Nat Methods; 2007 Feb; 4(2):147-52. PubMed ID: 17179933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ORBIT: a New Paradigm for Genetic Engineering of Mycobacterial Chromosomes.
    Murphy KC; Nelson SJ; Nambi S; Papavinasasundaram K; Baer CE; Sassetti CM
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium bovis BCG moreau is naturally deficient in homologous recombination.
    Schwarz MGA; Corrêa PR; Malaga W; Guilhot C; Mendonça-Lima L
    Tuberculosis (Edinb); 2020 Jul; 123():101956. PubMed ID: 32741533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional expression of the Flp recombinase in Mycobacterium bovis BCG.
    Song H; Niederweis M
    Gene; 2007 Sep; 399(2):112-9. PubMed ID: 17590537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of unmarked deletion mutants in mycobacteria.
    Song H; Wolschendorf F; Niederweis M
    Methods Mol Biol; 2009; 465():279-95. PubMed ID: 20560070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient and simple generation of unmarked gene deletions in Mycobacterium smegmatis.
    Shenkerman Y; Elharar Y; Vishkautzan M; Gur E
    Gene; 2014 Jan; 533(1):374-8. PubMed ID: 24100088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of avirulent mutants of Mycobacterium bovis with vaccine properties by the use of illegitimate recombination and screening of stationary-phase cultures.
    Collins DM; Wilson T; Campbell S; Buddle BM; Wards BJ; Hotter G; de Lisle GW
    Microbiology (Reading); 2002 Oct; 148(Pt 10):3019-3027. PubMed ID: 12368435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene replacement by homologous recombination in Mycobacterium bovis BCG.
    Norman E; Dellagostin OA; McFadden J; Dale JW
    Mol Microbiol; 1995 May; 16(4):755-60. PubMed ID: 7476169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG.
    Borsuk S; Mendum TA; Fagundes MQ; Michelon M; Cunha CW; McFadden J; Dellagostin OA
    Tuberculosis (Edinb); 2007 Nov; 87(6):474-80. PubMed ID: 17888740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex.
    Collins DM
    Immunol Cell Biol; 2000 Aug; 78(4):342-8. PubMed ID: 10947858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The uraA locus and homologous recombination in Mycobacterium bovis BCG.
    Aldovini A; Husson RN; Young RA
    J Bacteriol; 1993 Nov; 175(22):7282-9. PubMed ID: 8226675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant.
    Keller PM; Böttger EC; Sander P
    BMC Microbiol; 2008 Jul; 8():120. PubMed ID: 18637199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new site-specific integration system for mycobacteria.
    Murry J; Sassetti CM; Moreira J; Lane J; Rubin EJ
    Tuberculosis (Edinb); 2005; 85(5-6):317-23. PubMed ID: 16256438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the mycobacteriophage Ms6 attP core allows the integration of multiple vectors into different tRNAala T-loops in slow- and fast-growing mycobacteria.
    Vultos TD; Méderlé I; Abadie V; Pimentel M; Moniz-Pereira J; Gicquel B; Reyrat JM; Winter N
    BMC Mol Biol; 2006 Dec; 7():47. PubMed ID: 17173678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.